I 
119TH CONGRESS 
1ST SESSION H. R. 3288 
To amend titles XVIII and XIX of the Social Security Act to provide for 
coverage of prescription digital therapeutics under the Medicare and 
Medicaid programs, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 8, 2025 
Mr. HERN of Oklahoma (for himself and Mr. THOMPSON of California) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce, and in addition to the Committee on Ways and Means, 
for a period to be subsequently determined by the Speaker, in each case 
for consideration of such provisions as fall within the jurisdiction of the 
committee concerned 
A BILL 
To amend titles XVIII and XIX of the Social Security Act 
to provide for coverage of prescription digital thera-
peutics under the Medicare and Medicaid programs, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Access to Prescription 
Digital Therapeutics Act of 2025’’. 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 2. COVERAGE AND PAYMENT OF PRESCRIPTION DIG-
ITAL THERAPEUTICS UNDER THE MEDICARE 
PROGRAM. 
(a) PRESCRIPTION
DIGITAL
THERAPEUTIC
DE-
FINED.—Section 1861 of the Social Security Act (42 
U.S.C. 1395x) is amended by adding at the end the fol-
lowing new subsection: 
‘‘(nnn) PRESCRIPTION DIGITAL THERAPEUTIC.— 
The term ‘prescription digital therapeutic’ means a prod-
uct, device, internet application, or other technology 
that— 
‘‘(1) is cleared or approved under section 
510(k), 513(f)(2), or 515 of the Federal Food, 
Drug, and Cosmetic Act; 
‘‘(2) has a cleared or approved indication for 
the prevention, management, or treatment of a med-
ical disease, condition, or disorder; 
‘‘(3) primarily uses software to achieve its in-
tended result; and 
‘‘(4) is a device that is exempt from section 
502(f)(1) of the Federal Food, Drug, and Cosmetic 
Act under section 801.109 of title 21 of the Code of 
Federal Regulations (or any successor regulation).’’. 
(b) COVERAGE AS MEDICAL AND OTHER HEALTH 
SERVICE.—Section 1861(s)(2) of the Social Security Act 
(42 U.S.C. 1395x(s)(2)) is amended— 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
(1) in subparagraph (JJ), by adding ‘‘and’’ at 
the end; and 
(2) by adding at the end the following new sub-
paragraph: 
‘‘(KK) prescription digital therapeutics (as de-
fined in subsection (nnn)) furnished on or after Jan-
uary 1, 2026;’’. 
(c) REQUIREMENTS
FOR PRESCRIPTION DIGITAL 
THERAPEUTICS UNDER MEDICARE.—Part B of title 
XVIII of the Social Security Act (42 U.S.C. 1395j et seq.) 
is amended by inserting after section 1834A the following 
new section: 
‘‘SEC. 1834B. REQUIREMENTS FOR PRESCRIPTION DIGITAL 
THERAPEUTICS. 
‘‘(a) PAYMENT.— 
‘‘(1) IN GENERAL.—Not later than 1 year after 
the date of the enactment of this section, the Sec-
retary shall establish a payment methodology for 
manufacturers of prescription digital therapeutics, 
which may consist of a one-time payment or periodic 
payments, as determined appropriate by the Sec-
retary. 
‘‘(2) CONSIDERATIONS FOR PAYMENT METHOD-
OLOGY.—For purposes of establishing the payment 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
methodology under paragraph (1), the Secretary 
shall consider— 
‘‘(A) the actual list charge of such pre-
scription digital therapeutic; 
‘‘(B) the weighted median (calculated by 
arraying the distribution of all payment rates 
reported for the most recent period for which 
such rates were reported under subsection 
(c)(1) for each prescription digital therapeutic 
weighted by volume for each payor and each 
manufacturer) for such prescription digital 
therapeutic; 
‘‘(C) in the case of a prescription digital 
therapeutic that requires ongoing use, the 
amount for such ongoing use; and 
‘‘(D) other factors as determined by the 
Secretary. 
‘‘(b) CODING.— 
‘‘(1) IN
GENERAL.—Not later than 2 years 
after the date of the enactment of this section, the 
Secretary shall establish product-specific HCPCS 
codes for prescription digital therapeutic covered 
under this title. 
‘‘(2) TEMPORARY CODE.—The Secretary shall 
adopt temporary product-specific HCPCS codes for 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
purposes of providing payment under this title until 
a permanent product-specific HCPCS code has been 
established under paragraph (1). 
‘‘(c) MANUFACTURER REPORTING.— 
‘‘(1) IN GENERAL.—Not later than January 1, 
2026, and not less frequently than annually there-
after, each manufacturer of a prescription digital 
therapeutic covered under this title shall submit to 
the Secretary, at such time and in such manner as 
specified by the Secretary, a report describing— 
‘‘(A) the payment rate that was paid by 
each private payor for such prescription digital 
therapeutic during the period specified by the 
Secretary; 
‘‘(B) the volume of such prescription dig-
ital therapeutic distributed to each such payor 
for such period; and 
‘‘(C) the number of individual users of 
such prescription digital therapeutic for such 
period. 
‘‘(2) TREATMENT
OF
DISCOUNTS.—The pay-
ment rate reported by a manufacturer under para-
graph (1)(A) shall reflect all discounts, rebates, cou-
pons, and other price concessions, including those 
described in section 1847A(c)(3). 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(3) CIVIL MONETARY PENALTY.— 
‘‘(A) IN GENERAL.—If the Secretary deter-
mines that a manufacturer has failed to report, 
or made a misrepresentation or omission in re-
porting, information under this subsection with 
respect to a prescription digital therapeutic, the 
Secretary may apply a civil money penalty in an 
amount of up to $10,000 per day for each fail-
ure to report or each such misrepresentation or 
omission. 
‘‘(B) APPLICATION.—The provisions of 
section 1128A (other than subsections (a) and 
(b)) shall apply to a civil money penalty under 
this paragraph in the same manner as they 
apply to a civil money penalty or proceeding 
under section 1128A(a). 
‘‘(4) CONFIDENTIALITY.—Information reported 
under this subsection shall be treated in the same 
manner in which information disclosed by a manu-
facturer or a wholesaler of a covered outpatient drug 
is treated under section 1927(b)(3)(D). 
‘‘(d) DEFINITIONS.—For purposes of this section: 
‘‘(1) ACTUAL LIST CHARGE.—The term ‘actual 
list charge’ means the publicly available payment 
rate for a prescription digital therapeutic on the first 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
day that such prescription digital therapeutic is 
available for purchase by a private payor. 
‘‘(2) HCPCS.—The term ‘HCPCS’ means, with 
respect to an item, the code under the Healthcare 
Common Procedure Coding System (HCPCS) (or a 
successor code) for such item. 
‘‘(3) MANUFACTURER.—The term ‘manufac-
turer’ has the meaning given such term in section 
820.3(o) of title 21, Code of Federal Regulations (or 
any successor regulation). 
‘‘(4) PRESCRIPTION DIGITAL THERAPEUTIC.— 
The term ‘prescription digital therapeutic’ has the 
meaning given such term in section 1861(nnn). 
‘‘(5) PRIVATE
PAYOR.—The term ‘private 
payor’ has the meaning given such term in section 
1834A(a)(8).’’. 
SEC. 3. COVERAGE OF PRESCRIPTION DIGITAL THERA-
PEUTICS UNDER THE MEDICAID PROGRAM. 
Section 1905(a) of the Social Security Act (42 U.S.C. 
1396d(a)) is amended— 
(1) in paragraph (31), by striking ‘‘; and’’ and 
inserting a semicolon; 
(2) by redesignating paragraph (32) as para-
graph (33); and 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS
(3) by inserting after paragraph (31) the fol-
lowing new paragraph: 
‘‘(32) prescription digital therapeutics (as de-
fined in section 1861(nnn)); and’’. 
Æ 
VerDate Sep 11 2014 
22:28 May 16, 2025
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H3288.IH
H3288
ssavage on LAPJG3WLY3PROD with BILLS